Lab Explores Using A.I. Agents as Co-Scientists to Accelerate Drug Research
Audio narration · Coming soon
This announcement highlights a new approach in biomedical research where A.I. agents are being trained to act as co-scientists. The goal is to leverage A.I.'s capabilities to speed up the drug discovery process, building on its existing role as a powerful tool in scientific discovery.
Why this matters
PRISM scored this story 65/100 for interest.
Originally published by nyt
